Rethinking health-related quality of life in patients after cardiac surgery: the role of an enhanced recovery pathway
Published
August 24, 2026
Paper ID
PAP-000038
Status
Published
DOI
10.65712/tmj.test000296
Advance Services
Abstract
Background: Practice around an enhanced recovery pathway varies widely between centres. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Effects were consistent across prespecified subgroups. Effects were consistent across prespecified subgroups. Conclusion: Future work should test an enhanced recovery pathway in a pragmatic multicentre trial.
Introduction
Guidelines make only a weak recommendation on an enhanced recovery pathway. Earlier studies of an enhanced recovery pathway were small or single-centre.
Practice around an enhanced recovery pathway varies widely between centres. The cost of health-related quality of life to health systems is substantial. Guidelines make only a weak recommendation on an enhanced recovery pathway.
Discussion
Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. These findings suggest that an enhanced recovery pathway is associated with better health-related quality of life in patients after cardiac surgery.
Strengths include the sample size and blinded outcome assessment. These findings suggest that an enhanced recovery pathway is associated with better health-related quality of life in patients after cardiac surgery.
These findings suggest that an enhanced recovery pathway is associated with better health-related quality of life in patients after cardiac surgery. Residual confounding cannot be excluded. Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Residual confounding cannot be excluded. Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. These findings suggest that an enhanced recovery pathway is associated with better health-related quality of life in patients after cardiac surgery.
Strengths include the sample size and blinded outcome assessment. These findings suggest that an enhanced recovery pathway is associated with better health-related quality of life in patients after cardiac surgery. Implementation will depend on staffing, cost and local protocols.
Conclusions
An enhanced recovery pathway is a reasonable option for patients after cardiac surgery to improve health-related quality of life.
References
1. Yilmaz T, Dubois J, et al. Delayed cord clamping and time to diagnosis. Eur Heart J. 2012;129(6):299-1684.
2. Haddad G, Zhang U, et al. Early enteral nutrition and surgical site infection. Pediatrics. 2013;246(3):66-1360.
3. Silva K, Rossi Q, et al. Low-dose aspirin and patient satisfaction. JAMA. 2018;256(2):608-1730.
4. Andersen V, Herrera A, et al. SGLT2 inhibitors and patient satisfaction. Ann Intern Med. 2015;88(4):159-1355.
5. Tanaka E, Herrera X, et al. Point-of-care ultrasound and 30-day readmission. Ann Intern Med. 2024;215(7):415-1278.
6. Farouk V, Larsen N, et al. Low-dose aspirin and medication adherence. Crit Care Med. 2023;332(7):726-1433.
7. Novak F, Patel Q, et al. Low-dose aspirin and post-operative delirium. BMJ. 2015;257(2):737-1234.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
Eligible participants were patients after cardiac surgery. The primary outcome was health-related quality of life, assessed blind to allocation.
Eligible participants were patients after cardiac surgery. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
Eligible participants were patients after cardiac surgery. The primary outcome was health-related quality of life, assessed blind to allocation.
Eligible participants were patients after cardiac surgery. The primary outcome was health-related quality of life, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
Results
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.79 (95% CI 0.50 to 0.83).
| Group | n | Events |
|---|---|---|
| Control | 531 | 79 |
| Age < 65 | 709 | 11 |
| Control | 605 | 37 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.